Roche, Shape to Develop RNA-based Gene Therapies for Parkinson’s

Roche, Shape to Develop RNA-based Gene Therapies for Parkinson’s

304231

Roche, Shape to Develop RNA-based Gene Therapies for Parkinson’s

Shape Therapeutics and Roche have entered into a strategic collaboration and license agreement to develop RNA-based gene therapies for Parkinson’s, Alzheimer’s, and rare diseases. Under the terms of the agreement, Shape will use its proprietary RNA technologies to leverage molecular machinery already present in human cells to correct disease-causing mutations. The company will carry out preclinical studies to identify gene therapy candidates. Roche will be in charge of developing potential treatments identified through this work, and…

You must be logged in to read/download the full post.